FDC vs INDSWFTLAB: Stock Comparison

FDC Limited vs Ind-Swift Laboratories Limited

Live data: 22 July 2026, 2:52 PM IST • Source: NSE and company filings

FDC Limited is the larger company by market capitalisation. FDC Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Ind-Swift Laboratories Limited shows a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of FDC Limited and Ind-Swift Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FDC is more favourable on 9 of 13 scored metrics and INDSWFTLAB on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
FDC is the larger company
₹6,713 Cr vs ₹2,035 Cr
P/E Ratio
FDC has a lower P/E
23.94x vs 50.25x
P/B Ratio
INDSWFTLAB has a lower P/B
1.5x vs 2.71x
EPS
FDC has higher earnings per share
₹17.3 vs ₹4.84
Dividend Yield
FDC has a higher dividend yield
2.39% vs 0%
Revenue Growth (TTM YoY)
FDC has faster revenue growth
18.9% vs -66.6%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs -94.8%
Qtr Sales Growth
INDSWFTLAB has stronger quarterly sales growth
22.8% vs 18.9%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFDCINDSWFTLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricFDCINDSWFTLAB
Live Price₹410.9₹234.01
Day Change-0.57%-1.51%
Volume1.28 L3.77 L
52-Week High₹527.8₹248.45
52-Week Low₹312.95₹87.15
Distance from 52W High-22.15%-5.81%

Valuation

MetricFDCINDSWFTLAB
Market Cap₹6,713 Cr₹2,035 Cr
P/E Ratio23.94x50.25x
P/B Ratio2.71x1.5x
EPS₹17.3₹4.84
Book Value₹152.62₹165.77
Dividend Yield2.39%0%

Growth

MetricFDCINDSWFTLAB
Revenue Growth (TTM YoY)18.9%-66.6%
EPS Growth (TTM YoY)166.8%-94.8%
Qtr Sales Growth18.9%22.8%
Qtr Profit Growth167%9.35%

Profitability & Leverage

MetricFDCINDSWFTLAB
ROE12.5%3.87%
ROCE16.7%4.7%
Net Margin12.96%41.4%
Operating Margin15.9%7.03%
Debt to Equity0.01x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFDCINDSWFTLAB
Promoter Holding69.66%42.99% 3.49 pp
FII Holding1.4% 1 pp13.88% 0.45 pp
DII Holding6.31% 0.02 pp0% 0.68 pp
Public Holding22.63% 0.98 pp43.12% 2.38 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FDC Limited and Ind-Swift Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.